Hospital Quironsalud Barcelona

Barcelona, Catalonia 8023

0 studies enrolling now · 2 studies all time

What they study most

Locally Recurrent Breast Cancer, Metastatic Breast Cancer, Solid Tumors

Studies at this site

• A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Stopped early
• Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer — Stopped early